Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2001
[Fluoroquinolones: utilization in renal and urogenital tract infections]K Farker, K G Naber, R FünfstückDer Internist|December 16, 2003
[Oncologic pharmacotherapy of elderly patients]U Wedding, U Merkel, K Farker, et al.International Journal of Clinical Pharmacology and Therapeutics|March 26, 2002
Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigationK Farker, U Schotte, J Scheele, et al.International Journal of Clinical Pharmacology and Therapeutics|March 26, 2002
Assessment of ADRs associated with lipid-lowering agents recorded in the Department of Internal Medicine, University Hospital, JenaM Hippius, K Farker, S Helble, et al.Biological Signals and Receptors|March 23, 1999
A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement therapyA Hoffmann, K Farker, M Dittgen, et al.International Journal of Clinical Pharmacology and Therapeutics|January 24, 2006
Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigationK Farker, U Merkel, U Wedding, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humansK Farker, L Henschel, J P Marschner, et al.Die Pharmazie|May 1, 1993
[The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)]K Farker, L Henschel, J P Marschner, et al.International Journal of Clinical Pharmacology and Therapeutics|March 23, 2006
Pharmacokinetics of oxaliplatin and non-hematological toxicity in metastatic gastrointestinal cancer patients treated with chronomodulated oxaliplatin, 5-FU and sodium folinate in a pilot investigationU Merkel, K Farker, U Wedding, et al.International Journal of Clinical Pharmacology and Therapeutics|March 1, 1997
Bioavailability study with 2 different levonorgestrel-containing drugs in womenN Nassr, K Farker, M Lautenschlager, et al.Pageof 3